Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Study on the Impact of a Specialized Oral Nutritional Supplement on Muscle Mass and Chemotherapy Tolerance in Pancreatic Cancer Patients

NCT07870421 is registered in ClinicalTrials.gov with Nutricia Research as lead sponsor.

NCT NCT07870421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07870421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Study on the Impact of a Specialized Oral Nutritional Supplement on Muscle Mass and Chemotherapy Tolerance in Pancreatic Cancer Patients
Lead sponsor
Nutricia Research
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
March 1, 2030
Enrollment
216 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic ductal adenocarcinoma (pdac)